Business
Breaking News: Imminent Cannabis Legalization To Make Cannabis Industry Next Big Bio-Pharma Sector
Breaking News: Imminent Cannabis Legalization To Make Cannabis Industry Next Big Bio-Pharma Sector.

About this update from American Premium Water Corporation
[{"type":"text","content":"\nLegislation will legalize many forms of Cannabis, including CBD, allowing for institutional investment\n NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Cannagreed.com News Commentary Nine states and Washington, D.C. have legalized recreational marijuana; many other states have legalized medical marijuana, and there are several ballot initiatives in next month’s elections where many other states will become medical and recreational legal.  And with the anticipated passage of the 2018 Farm Bill, it will remove Hemp as a controlled substance, making CBD, which is derived from the plant, legal under federal law. The legalization of hemp will present endless investment opportunities. Companies in the CBD space will surely see a rise in valuations, as many more outlets will now be able to sell CBD products because the grey area around if it’s classified as a controlled substance will be lifted. These companies will also see an increase in conventional and institutional investment as well, which will also contribute to the increase in valuations. Investor interest in CBD, a non-psychoactive component of marijuana, increased after the Drug Enforcement Administration said Thursday it now places FDA-approved drugs with CBD in “Schedule V,” defined as having the lowest potential for abuse. Other products that are classified as Schedule V are over-the-counter treatments for diarrhea, cough suppressants, and muscle relaxers. Brightfield Group, a cannabis research firm, recently raised its projections for the CBD industry, stating that it could reach $22 billion in market size by 2022. Bobby Burleson, an analyst at Cannacord Genuity, expects that market share for cannabis-infused beverages “should expand meaningfully over the next several years,” outpacing overall retail demand for marijuana by more than 2x. Marc Lustig, CEO of CannaRoyalty said, “Many beverage companies see the opportunity of cannabis, which could compete with or replace the alcohol business.” A company well positioned for the legalization of CBD is American Premium Water Corporation, (OTC:HIPH) whose stock rose over 600% after the company announced that it had launched its CBD beverage, LALPINA Hydro CBD. The California-based company is the first to market a hydro-nano CBD infused beverage on the market, which is a more ef...